Sheng et al. used Bifidobacterium to treat mice with ulcerative colitis and found that Bifidobacterium intervention could significantly reduce the disease activity index and intestinal pathology scores and might significantly downregulate the TNF-α and IL-1β levels in colon tissue [24]. The gene discussed is TNF; the disease is ulcerative colitis.